CA
NZ
UK
AU
IND
US
Bristol Myers Squibb (NYSE:BMY) fell USD 0.95 to USD 56.63 on 12.927 million shares, about 1.2 times its 3-month average of 11.217 million. The news was positive but mixed: the Phase 3 trial of admilparant in idiopathic pulmonary fibrosis met its primary endpoint at …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. China Pharma Holdings is a Haikou-based specialty pharmaceutical company with eight GMP-certified product lines, listed on NYSE American. NYSE American …
Hyperfine, maker of the Swoop portable MRI brain imaging system, issued a preliminary third-quarter 2026 update showing revenue of about USD 6.0 million, up roughly 53% sequentially and about 55% year over year, and net cash burn of about USD 5.6 million, down about …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and began trading as …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. Onconetix is a Cincinnati-based commercial-stage biotechnology company that owns Proclarix, an in vitro diagnostic blood test used with PSA to …
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. RedHill Biopharma, a Tel Aviv and Raleigh specialty pharmaceutical company, sold its 70% stake in Talicia to Apotex for USD …
DRI Healthcare Trust moved from an implied USD 12.79 to USD 11.62 on only 519 units, so a single small order could explain the whole decline. No company release, filing or analyst note dated October 13, 2026 was found. Relative volume of 1.38 sounds …
Eupraxia moved from an implied CAD 10.63 to CAD 9.66 on 45.74 thousand shares, 0.40 times average. The shares also trade in the United States, where they closed near USD 7.46 on October 12 after an October high of USD 9.12, a drop of …
● MDT shares rose 3.90% to $91.93 in Monday’s session on 36.56 million shares, about $3.36 billion traded and 18th among US stocks.
No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. DataMeds AI, a Tampa-based health IT company that changed its name from Wellgistics Health in July and moved its ticker …
Please wait processing your request...